<b> <i>Retracted:</i> </b> Naringenin Inhibits Cell Migration, Invasion, and Tumor Growth by Regulating circFOXM1/miR-3619-5p/SPAG5 Axis in Lung Cancer

Abstract

<i>Cancer Biotherapy and Radiopharmaceuticals</i> officially retracts the article entitled, "Naringenin Inhibits Cell Migration, Invasion, and Tumor Growth by Regulating circFOXM1/miR-3619-5p/SPAG5 Axis in Lung Cancer" by Zhaofeng Tan, Yuli Sun, Mei Liu, Lei Xia, Fang Cao, Yuanfu Qi, and Yonglei Song, (Cancer Biother Radiopharm; E-pub 27 Jun 2020; doi: 10.1089/cbr.2019.3520) at the authors' request: <i>"...we feel that we have not yet studied our work completely and some new great results are discovered. So after carefully thinking, we are going to rearrange this manuscript and try to give more precise model. Thus we decided to withdraw this manuscript with great pity. We sincerely say sorry for all the staffs involved this manuscript including editors, reviewers etc. because of our action."[sic]</i> After careful consideration, the Editor agreed to retract the paper. The Editor and Publisher of <i>Cancer Biotherapy and Radiopharmaceuticals</i> are committed to preserving the scientific literature and the community it serves.